A framework for prioritizing genetic variants for animal modeling in rare disease

This Primer proposes a structured framework for prioritizing genetic variants for animal modeling in rare disease. Drawing on the experience of the Congenital Anomalies Cluster of the UK MRC National Mouse Genetics Network (NMGM), we outline a three-step process: first, rigorous curation of clinical, molecular, and functional evidence to establish biological plausibility and define a mechanistic hypothesis; second, assessment and selection of the most appropriate model capable of addressing the question; and third, integration of practical and ethical considerations, prioritizing variants with clinical actionability, stronger cohorts, and mechanistic potential.

Authors

Institutions

Publication Details

Journal
STAR Protocols
Published
2026-11-19
DOI
https://doi.org/10.1016/j.xpro.2026.104983
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A framework for prioritizing genetic variants for animal modeling in rare disease

Juliana Heather Vedovato dos Santos, Deborah J. Henderson, Karen J. Liu, Stephen R.F. Twigg et al.
STAR Protocols
Genomics and Rare Diseases
article

A framework for prioritizing genetic variants for animal modeling in rare disease

Juliana Heather Vedovato dos Santos, Deborah J. Henderson, Karen J. Liu, Stephen R.F. Twigg, Pleasantine Mill, Nicholas D. E. Greene
article en

Abstract

This Primer proposes a structured framework for prioritizing genetic variants for animal modeling in rare disease. Drawing on the experience of the Congenital Anomalies Cluster of the UK MRC National Mouse Genetics Network (NMGM), we outline a three-step process: first, rigorous curation of clinical, molecular, and functional evidence to establish biological plausibility and define a mechanistic hypothesis; second, assessment and selection of the most appropriate model capable of addressing the question; and third, integration of practical and ethical considerations, prioritizing variants with clinical actionability, stronger cohorts, and mechanistic potential.

STAR ProtocolsVol. 7(4)
King's College London (GB), John Radcliffe Hospital (GB), University of Oxford (GB), Mary Lyon Centre at MRC Harwell (GB), MRC Weatherall Institute of Molecular Medicine (GB), Institute of Genetics and Cancer (GB), University College London (GB), Newcastle University (GB)
Medical Research Council
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon